Mark Nagel
Impact in
-
- Inhalation and Respiratory Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Inhalation and Respiratory Drug Delivery 45
- Cystic Fibrosis Research Advances 4
-
- Aerosol Filtration and Electrostatic Precipitation 7
- Co-authors
- Jolyon P. Mitchell (39 shared papers)Hans‐Peter Gerber (1 shared paper)Ming-Hong Xie (1 shared paper)Sarah Bodary (1 shared paper)Daniel Sherman (1 shared paper)Austin Gurney (1 shared paper)Kevin Clark (1 shared paper)N. Ferrara (1 shared paper)
- Journals
- AAPS PharmSciTech (7 papers)Respiratory Care (7 papers)European Respiratory Journal (2 papers)Aerosol Science and Technology (2 papers)PLoS Pathogens (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark Nagel
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Pulmonary and Respiratory Medicine 889
- Pharmaceutical Science 89
- Virology 51
- Hematology 115
- Cardiology and Cardiovascular Medicine 169
Countries citing papers authored by Mark Nagel
This map shows the geographic impact of Mark Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nagel more than expected).
Fields of papers citing papers by Mark Nagel
This network shows the impact of papers produced by Mark Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nagel. The network helps show where Mark Nagel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Nagel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 210 | |
| 2 | 2003 | 156 | |
| 3 | 1997 | 128 | |
| 4 | 2006 | 88 | |
| 5 | 2003 | 84 | |
| 6 | 2004 | 58 | |
| 7 | 2007 | 52 | |
| 8 | 1999 | 49 | |
| 9 | 2019 | 43 | |
| 10 | 2007 | 42 | |
| 11 | 1997 | 37 | |
| 12 | 2009 | 31 | |
| 13 | 2002 | 29 | |
| 14 | 2010 | 27 | |
| 15 | 2006 | 27 | |
| 16 | 2006 | 26 | |
| 17 | 2022 | 24 | |
| 18 | 2009 | 24 | |
| 19 | 1999 | 20 | |
| 20 | [Portography by transparietal splenic route]. | 1951 | 19 |
About Mark Nagel
Mark Nagel is a scholar working on Pulmonary and Respiratory Medicine, Electrical and Electronic Engineering, Pediatrics, Perinatology and Child Health, Ocean Engineering and Physiology, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (45 papers), Aerosol Filtration and Electrostatic Precipitation (7 papers), Particle Dynamics in Fluid Flows (6 papers), Asthma and respiratory diseases (6 papers), Pharmaceutical studies and practices (6 papers), Air Quality and Health Impacts (4 papers), Cyclone Separators and Fluid Dynamics (4 papers) and Cystic Fibrosis Research Advances (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (889 citations), Pharmaceutical Science (89 citations), Virology (51 citations), Hematology (115 citations) and Cardiology and Cardiovascular Medicine (169 citations). Mark Nagel has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Jolyon P. Mitchell, Hans‐Peter Gerber, Ming-Hong Xie, Sarah Bodary, Daniel Sherman, Austin Gurney, Kevin Clark, N. Ferrara, M. Teresa Pisabarro and Gieri Camenisch. Their work appears in journals such as AAPS PharmSciTech, Respiratory Care, European Respiratory Journal, Aerosol Science and Technology and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.